Gene · 3984
Papers2,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of p21-Activated Kinases in Cancer and Beyond: Where Are We Heading? | Front Cell Dev Biol | 2021 | 33796531 | PubTator, text mining | PubMed |
| Pyr1-Mediated Pharmacological Inhibition of LIM Kinase Restores Synaptic Plasticity and Normal Behavior in a Mouse Model of Schizophrenia. | Front Pharmacol | 2021 | 33790791 | PubTator, text mining | PubMed |
| Perspectives on ROCK2 as a Therapeutic Target for Alzheimer's Disease. | Front Cell Neurosci | 2021 | 33790742 | PubTator, text mining | PubMed |
| MiR-509-3p Induces Apoptosis and Affects the Chemosensitivity of Cervical Cancer Cells by Targeting the RAC1/PAK1/LIMK1/Cofilin Pathway. | Chem Pharm Bull (Tokyo) | 2021 | 33790078 | PubTator, text mining | PubMed |
| The role of CPEB family proteins in the nervous system function in the norm and pathology. | Cell Biosci | 2021 | 33789753 | PubTator, text mining | PubMed |
| Epigenomic tensor predicts disease subtypes and reveals constrained tumor evolution. | Cell Rep | 2021 | 33789109 | PubTator, text mining | PubMed |
| Hypoxia-induced cofilin 1 promotes hepatocellular carcinoma progression by regulating the PLD1/AKT pathway. | Clin Transl Med | 2021 | 33784016 | PubTator, text mining | PubMed |
| MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells. | Oncol Lett | 2021 | 33777215 | PubTator, text mining | PubMed |
| BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma. | Oncol Lett | 2021 | 33777214 | PubTator, text mining | PubMed |
| Promoter Hypermethylation of LATS1 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population. | Asian Pac J Cancer Prev | 2021 | 33773564 | PubTator, text mining | PubMed |
| FOXD3‑AS1/miR‑128‑3p/LIMK1 axis regulates cervical cancer progression. | Oncol Rep | 2021 | 33760158 | PubTator, text mining | PubMed |
| Protein Biomarkers of Autism Spectrum Disorder Identified by Computational and Experimental Methods. | Front Psychiatry | 2021 | 33716802 | PubTator, text mining | PubMed |
| Epithelial-mesenchymal transition-related circular RNAs in lung carcinoma. | Cancer Biol Med | 2021 | 33710806 | PubTator, text mining | PubMed |
| The epithelial-mesenchymal transition and the cytoskeleton in bioengineered systems. | Cell Commun Signal | 2021 | 33691719 | PubTator, text mining | PubMed |
| Combinatorial mathematical modelling approaches to interrogate rear retraction dynamics in 3D cell migration. | PLoS Comput Biol | 2021 | 33690598 | PubTator, text mining | PubMed |
| LIMK1 nuclear translocation promotes hepatocellular carcinoma progression by increasing p-ERK nuclear shuttling and by activating c-Myc signalling upon EGF stimulation. | Oncogene | 2021 | 33686242 | PubTator, text mining | PubMed |
| Actin Cytoskeleton and Regulation of TGFβ Signaling: Exploring Their Links. | Biomolecules | 2021 | 33672325 | PubTator, text mining | PubMed |
| Human Costars Family Protein ABRACL Modulates Actin Dynamics and Cell Migration and Associates with Tumorigenic Growth. | Int J Mol Sci | 2021 | 33670794 | PubTator, text mining | PubMed |
| Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma. | J Exp Pharmacol | 2021 | 33664600 | PubTator, text mining | PubMed |
| Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer. | Sci Rep | 2021 | 33664322 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3984/papers?page=42